Application of a method used to deconstruct a single dose pharmacokinetic profile from multiple dose data

By  

Biopharmaceutics And Drug Disposition, Vol. 36, Iss. 6, 2015-09 ,pp. : 405-409

John Wiley & Sons Inc

Access to resources Recommend Favorite

Justification of the starting dose as the main determinant of accrual time in dose-seeking oncology phase 1 trials

By Penel Nicolas   Leblond Pierre   Lansiaux Amélie   Clisant Stéphanie   Dansin Eric   Adenis Antoine   Bonneterre Jacques  

Investigational New Drugs, Vol. 28, Iss. 6, 2010-12 ,pp. : 839-843

Springer Publishing Company

Access to resources Recommend Favorite

Safety profile of standard- vs. high-dose peginterferon alfa-2a plus standard-dose ribavirin in HCV genotype 1/4 patients: pooled analysis from 5 randomized studies

By Marcellin Patrick   Roberts Stuart K   Reddy K Rajender   Harrison Stephen A   Jensen Donald M   Hadziyannis Stephanos   Diago Moises   Weltman Martin   Messinger Diethelm   Tatsch Fernando   Rizzetto Mario  

Expert Opinion on Drug Safety, Vol. 11, Iss. 6, 2012-11 ,pp. : 901-909

Informa Healthcare

Access to resources Recommend Favorite

Cytotoxicity and Antiviral Activity of a Lignan Extracted from Larrea divaricata

By  

Drug Design Reviews - Online, Vol. 2, Iss. 1, 2005-02 ,pp. : 81-83

Bentham Science Publishers

Access to resources Recommend Favorite

Opioid activity of alkaloids extracted from Picralima nitida (fam. Apocynaceae)

By Menzies J.R.W.   Paterson S.J.   Duwiejua M.   Corbett A.D.  

European Journal of Pharmacology, Vol. 350, Iss. 1, 1998-05 ,pp. : 101-108

Elsevier

Access to resources Recommend Favorite